Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein H3 pseudogene 1 (HNRNPH3P1)

Target
HNRNPH3P1
Molecular classification
Other, Pseudogene
01

Overview

Heterogeneous nuclear ribonucleoprotein H3 pseudogene 1 (HNRNPH3P1) is classified as a pseudogene, which means it is a non-functional segment of DNA resembling a protein-coding gene but lacks the ability to produce a functional protein. Unlike its parental functional gene (HNRNPH3, which encodes an RNA-binding protein involved in mRNA processing), HNRNPH3P1 is not known to encode a functional protein product or to act as a therapeutic target. There is currently no established biological function, disease association, or evidence that it serves as a clinically relevant receptor, enzyme, or other druggable target. Notes: - This entry is not considered a drug discovery or therapeutic target (such as a receptor, enzyme, or transporter); it is a pseudogene and generally not directly involved in cell signaling, disease pathways, or pharmacology. - Current scientific consensus does not indicate a functional role in disease or an interaction with drugs, and information specific to biomarkers or safety concerns does not exist. - Some pseudogenes may be transcribed and potentially have regulatory functions in specific contexts, but HNRNPH3P1 has not been identified as functionally relevant in these capacities to date. - The query is technically “incorrect” regarding therapeutic target classification.

Other names
HNRNPH3P1

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein H3 pseudogene 1 (HNRNPH3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein H3 pseudogene 1 (HNRNPH3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call